HIV-related lipodystrophy and facial lipoatrophy: The role of Restylane SubQ in reversing facial wasting

HIV-associated lipodystrophy syndrome affects approximately 50% of HIV-positive patients, particularly those receiving antiretroviral therapy based on nucleoside reverse transcriptase inhibitors and protease inhibitors. Growing evidence suggests that cert